EUCURE BIOPHARMA
Eucure Biopharma is a global biotechnology company headquartered in Beijing, China. They are committed to the discovery and development of innovative immuno-oncology targeted antibodies which mainly focus on immune checkpoints. Several products have entered the CMC stage and has applied for clinical trial in 2019. Their mission is to develop antibody treatments to improve the survival rate of tumor patients.
EUCURE BIOPHARMA
Industry:
Biotechnology Health Care Health Diagnostics Pharmaceutical
Founded:
2016-11-01
Address:
Beijing, Beijing, China
Country:
China
Website Url:
http://www.eucure.com
Total Employee:
11+
Status:
Active
Contact:
86-10-5631-5309
Email Addresses:
[email protected]
Total Funding:
250 M CNY
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Domain Not Resolving Mobile Non Scaleable Content Nginx Euro Microsoft Exchange Online Office 365 Mail
Similar Organizations
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Vor Biopharma
Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.
Current Employees Featured
Founder
Investors List
3E Bioventures
3E Bioventures investment in Series B - Eucure Biopharma
CMB International Capital Corporation
CMB International Capital Corporation investment in Series B - Eucure Biopharma
SDIC Venture Capital
SDIC Venture Capital investment in Series A - Eucure Biopharma
BVCF
BVCF investment in Series A - Eucure Biopharma
BVCF
BVCF investment in Series A - Eucure Biopharma
SDIC Venture Capital
SDIC Venture Capital investment in Series A - Eucure Biopharma
More informations about "Eucure Biopharma"
Eucure Biopharma - Crunchbase Company Profile & Funding
Organization. Eucure Biopharma . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Eucure Biopharma is a …See details»
Youhe Medical Technology (Beijing) Co. Ltd. - Drug pipelines, …
Eucure Biopharma, a subsidiary of Biocytogen Pharmaceuticals (Beijing) Co., Ltd., is a biotechnology company headquartered in Beijing, China. Specializing in the discovery and …See details»
Eucure - Eucure
Eucure Biopharma owns a seasoned team with in-depth experience in global clinical development, and is dedicated to providing a comprehensive range of professional services, …See details»
Eucure Biopharma Company Profile 2024: Valuation, Investors
Eucure Biopharma General Information Description. Developer of antibody pharmaceuticals to treat tumors. The company's pharmaceuticals help patients develop checkpoint and cancer …See details»
Eucure Biopharma Company Profile - Office Locations ... - Craft
Eucure Biopharma $78.96 m in total funding,. See insights on Eucure Biopharma including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
祐和医药科技（北京）有限公司_祐和医药
祐和医药科技(北京)有限公司(简称“祐和医药”)是一家成立于2016年11月位于北京经济技术开发区、致力于创新抗体药物研发的 ...See details»
Eucure Biopharma, a Subsidiary of Biocytogen Pharmaceuticals, …
Oct 18, 2022 Eucure will be responsible for drug manufacturing and supply, and Syncromune will be responsible for clinical development and commercialization. The Syncrovax™ platform …See details»
Syncromune, Inc. Enters into an Exclusive Worldwide License …
Oct 18, 2022 FORT LAUDERDALE, FL. and BEIJING, China, October 18, 2022 (BUSINESS WIRE) – Syncromune, Inc., a clinical stage biopharmaceutical company focused on the …See details»
Eucure Biopharma, a Subsidiary of Biocytogen ... - Business Wire
Oct 18, 2022 Eucure Biopharma, a Subsidiary of Biocytogen Pharmaceuticals, Licenses OX40 Antibody (YH002) and Multiple Active Ingredients to Syncromune for the Development and …See details»
Eucure and Syncromune Establish Technology Transfer Agreement …
Aug 30, 2023 FORT LAUDERDALE, FL. and BEIJING, China, October 18, 2022 (BUSINESS WIRE) – Syncromune, Inc., a clinical stage biopharmaceutical company focused on the …See details»
Eucure and Syncromune Establish Technology Transfer
Aug 30, 2023 Eucure (Beijing) Biopharma Co., Ltd. (“Eucure”), a wholly owned subsidiary of Biocytogen, announced today that the company has entered into a technology transfer …See details»
Eucure Biopharma, Syncromune To Develop Intratumoral …
Oct 20, 2022 Beijing-based Eucure Biopharma, a subsidiary of Biocytogen Pharmaceuticals, and US-based Syncromune Inc. have entered a licensing agreement that will combine Eucure’s …See details»
Biocytogen Announces the Merger of Eucure Biopharma to Create …
The clinical application and development capabilities of Eucure Biopharma complement each other with the highly effective preclinical new drug development system of the Biocytogen. …See details»
Eucure Biopharma, a Subsidiary of Biocytogen, Announces …
Nov 1, 2022 YH003 is an agonistic anti-CD40 IgG2 monoclonal antibody with best-in-class potential. YH003 in combination with PD-1 are being dosed in phase II multi-regional clinical …See details»
TRACON Pharmaceuticals and Eucure Biopharma, a Subsidiary
Oct 11, 2021 TRACON Contacts: Company Contact: Investor Contact: Mark Wiggins: Brian Ritchie: Chief Business Officer: LifeSci Advisors LLC (858) 251-3492 (212) 915-2578See details»
Eucure Biopharma Announces Breakthrough Phase I Results for …
Mar 22, 2021 Eucure Biopharma is a biotechnology company that focuses on the clinical development of antibody drugs with independent intellectual property rights. Eucure …See details»
Syncromune, Inc. Enters into an Exclusive Worldwide ... - Business …
Oct 18, 2022 Eucure will be responsible for drug manufacturing and supply, and Syncromune will be responsible for clinical development and commercialization. The Syncrovax™ platform …See details»
Play Euchre Card Game Online - Euchre.com
Play Euchre online for free, no download required. Different game options are available. Try multiple Euchre variations, practice and compete in tournaments.See details»
Patient Care - Eucure - Eucure
----- Tumor Immunity ----- Normally, the immune system can recognize and eliminate tumor cells from the tumor microenvironment; however, tumor cells can suppress the human immune …See details»